Literature DB >> 21988947

Complications from catheter ablation of atrial fibrillation: a systematic review.

Abhishek Maan1, Amir Y Shaikh, Moussa Mansour, Jeremy N Ruskin, E Kevin Heist.   

Abstract

Atrial fibrillation (AF) is the most common arrhythmia requiring treatment that is encountered in clinical practice. Recent advances in the understanding of underlying mechanisms of AF have led to the increased use of catheter ablation (CA) as a treatment modality for paroxysmal, persistent, or long-standing persistent AF in patients with symptomatic AF despite treatment with antiarrhythmic medications. Because of the complexity in technique and anatomic location of the ablation sites, it is not surprising that CA of AF is associated with a greater risk of procedural complications compared with simpler cardiac ablation procedures. Major and minor complications, including life-threatening complications, have been described and quantified. This systematic review describes the potential risks of CA that have been reported over a period and provides insights into the evolving strategies to minimize these complications, thus making CA techniques safer and potentially more efficacious for AF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21988947     DOI: 10.1097/HPC.0b013e318224b7bd

Source DB:  PubMed          Journal:  Crit Pathw Cardiol        ISSN: 1535-2811


  12 in total

Review 1.  Pulmonary vein stenosis: Etiology, diagnosis and management.

Authors:  Pablo Pazos-López; Cristina García-Rodríguez; Alba Guitián-González; Emilio Paredes-Galán; María Ángel De La Guarda Álvarez-Moure; Marta Rodríguez-Álvarez; José Antonio Baz-Alonso; Elvis Teijeira-Fernández; Francisco Eugenio Calvo-Iglesias; Andrés Íñiguez-Romo
Journal:  World J Cardiol       Date:  2016-01-26

2.  Out, damned spot....

Authors:  Lucy Rose Grace Shimwell; Rannie Nahas; Muhammad Javaid Hameed Rahmani
Journal:  BMJ Case Rep       Date:  2015-08-06

Review 3.  Practical issues in the management of novel oral anticoagulants-cardioversion and ablation.

Authors:  Abhishek Maan; E Kevin Heist; Jeremy N Ruskin; Moussa Mansour
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

Review 4.  Atrial fibrillation inducibility during cavotricuspid isthmus-dependent atrial flutter ablation as a predictor of clinical atrial fibrillation. A meta-analysis.

Authors:  Jorge Romero; Juan Carlos Diaz; Luigi Di Biase; Saurabh Kumar; David Briceno; Usha B Tedrow; Carolina R Valencia; Samuel H Baldinger; Bruce Koplan; Laurence M Epstein; Roy John; Gregory F Michaud; William G Stevenson
Journal:  J Interv Card Electrophysiol       Date:  2017-01-09       Impact factor: 1.900

5.  Brain and spinal cord infarcts secondary to an atrial-esophageal fistula.

Authors:  Swetha Renati; Cui Yang; Meggen Walsh; Jorge Trejo-Lopez; Anna Khanna
Journal:  Neurol Clin Pract       Date:  2017-10

6.  A Treatment Planning Study of Stereotactic Body Radiotherapy for Atrial Fibrillation.

Authors:  Ping Xia; Rupesh Kotecha; Naveen Sharma; Martin Andrews; Kevin L Stephans; Carlos Oberti; Sara Lin; Oussama Wazni; Patrick Tchou; Walid I Saliba; John Suh
Journal:  Cureus       Date:  2016-07-11

Review 7.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

Review 8.  The incidence, diagnosis, and management of pulmonary vein stenosis as a complication of atrial fibrillation ablation.

Authors:  Armand Rostamian; Sanjiv M Narayan; Louise Thomson; Michael Fishbein; Robert J Siegel
Journal:  J Interv Card Electrophysiol       Date:  2014-03-14       Impact factor: 1.900

9.  Current Evidence and Recommendations for Rate Control in Atrial Fibrillation.

Authors:  Abhishek Maan; Moussa Mansour; Jeremy N Ruskin; E Kevin Heist
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-04

10.  Reactive oxygen species-targeted therapeutic interventions for atrial fibrillation.

Authors:  Ali A Sovari; Samuel C Dudley
Journal:  Front Physiol       Date:  2012-08-06       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.